Acneiform Eruptions

1. Józwiak S, Schwartz RA, Janniger CK, Michalowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998 Dec. 37(12):911-7. [Medline].

2. Song MG, Park KB, Lee ES. Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner. Dermatol Surg. 1999 Dec. 25(12):970-3. [Medline].

3. Harden D, Keeling JH. Papular and nodular lesions of the scalp, face, and neck. Secondary syphilis. Arch Dermatol. 1997 Aug. 133(8):1027, 1030. [Medline].

4. Lambert WC, Bagley MP, Khan Y, Schwartz RA. Pustular acneiform secondary syphilis. Cutis. 1986 Jan. 37(1):69-70. [Medline].

5. Kusuhara M, Hachisuka H, Sasai Y. Statistical survey of 150 cases with sporotrichosis. Mycopathologia. 1988 May. 102(2):129-33. [Medline].

6. Held JL, Andrew JE, Toback AC. Eruptive vellus hair cysts. Cutis. 1987 Sep. 40(3):259-60. [Medline].

7. Fung MA, Berger TG. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids. Dermatology. 2000. 200(1):43-4. [Medline].

8. Hurwitz RM. Steroid acne. J Am Acad Dermatol. 1989 Dec. 21(6):1179-81. [Medline].

9. Farella V, Sberna F, Knöpfel B, Urso C, Difonzo EM. Acne-like eruption caused by amineptine. Int J Dermatol. 1996 Dec. 35(12):892-3. [Medline].

10. Grimalt R, Mascaró-Galy JM, Ferrando J, Lecha M. Guess what? Macronodular iatrogenic acne due to amineptine. Eur J Dermatol. 1999 Sep. 9(6):491-2. [Medline].

11. Vexiau P, Gourmel B, Castot A, Husson C, Rybojad M, Julien R, et al. Severe acne due to chronic amineptine overdose. Arch Dermatol Res. 1990. 282(2):103-7. [Medline].

12. Schalock PC, Zug KA. Acneiform reaction to erlotinib. Dermatitis. 2007 Dec. 18(4):230-1. [Medline].

13. Eames T, Landthaler M, Karrer S. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor. Eur J Dermatol. 2007 Nov-Dec. 17(6):552-3. [Medline].

14. Gencoglan G, Ceylan C. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Skin Pharmacol Physiol. 2007. 20(5):260-2. [Medline].

15. DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol. 2007 Mar. 56(3):500-5. [Medline].

16. Santoro F, Cozzani E, Parodi A. Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor. J Dermatolog Treat. 2006. 17(3):160-1. [Medline].

17. Journagan S, Obadiah J. An acneiform eruption due to erlotinib: prognostic implications and management. J Am Acad Dermatol. 2006 Feb. 54(2):358-60. [Medline].

18. Myskowski PL, Halpern AC. Skin reactions to the new biologic anticancer drugs. Curr Opin Support Palliat Care. 2009 Dec. 3(4):294-9. [Medline].

19. Jung YS, Kim M, Lee JH, Cho BK, Kim DW, Park HJ. Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia. Br J Dermatol. sept 24 2015. 10.1111:[Medline].

20. Sherertz EF. Acneiform eruption due to "megadose" vitamins B6 and B12. Cutis. 1991 Aug. 48(2):119-20. [Medline].

21. Monk B, Cunliffe WJ, Layton AM, Rhodes DJ. Acne induced by inhaled corticosteroids. Clin Exp Dermatol. 1993 Mar. 18(2):148-50. [Medline].

22. Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Patho. April 2015. 42:265-270. [Medline].

23. Deza G, Vidal A, Gallardo F, Iranzo P, Canal de la Iglesia L, Pujol RM. Generalized Necrobiotic Palisading Granulomatous Follicular Eruption: A Peculiar Pustular Variant of Perforating Granuloma Annulare or an Individualized Disease?. Am J Dermatopathol. 2019 Jul 12. [Medline].

Julianne H Kuflik, MD Assistant Clinical Professor of Dermatology, Department of Dermatology, Rutgers New Jersey Medical School

Julianne H Kuflik, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Joshua A Zeichner, MD Assistant Professor, Director of Cosmetic and Clinical Research, Mount Sinai School of Medicine; Chief of Dermatology, Institute for Family Health at North General

Joshua A Zeichner, MD is a member of the following medical societies: American Academy of Dermatology, National Psoriasis Foundation

Disclosure: Received consulting fee from Valeant for consulting; Received grant/research funds from Medicis for other; Received consulting fee from Galderma for consulting; Received consulting fee from Promius for consulting; Received consulting fee from Pharmaderm for consulting; Received consulting fee from Onset for consulting.

• Print this section
• Print the entire contents of
• Print the entire contents of article